Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Kura Oncology, Inc.
Kura Oncology, Inc.
Ascentage Pharma Group Inc.
BlossomHill Therapeutics
Celgene
Novartis
Celularity Incorporated
AbbVie
Celgene
Eli Lilly and Company
PTC Therapeutics
Hutchmed
Eli Lilly and Company
Hoffmann-La Roche
Amgen
Hoffmann-La Roche
Exelixis
Merck Sharp & Dohme LLC
AstraZeneca
Sanofi
Celgene